EN) Hsin CH, et al, High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in ... 96, n. 11, Oxford University Press, 2 giugno 2004, pp. 853-861, DOI:10.1093/jnci/djh144, PMID 15173269. ^ (EN) Gupta P C, Meht ... 11, n. 1, Springer, 25 marzo 2015, p. 6, DOI:10.1186/s13005-015-0063-z, PMID 25889859, PMC 4396078. ^ (EN) Gupta S, et al, ... 8, n. 11, PLOS, 18 novembre 2013, p. e78999, DOI:10.1371/journal.pone.0078999, PMID 24260143, PMC 3832519. ^ (EN) The impact of ...
... in Human Dermal Fibroblasts Abrogates UVA Irradiation-induced Expression of Interstitial Collagenase/Matrix Metalloproteinase-1 ... 49, n. 11-12, 2004, pp. 1853-61. ^ (EN) Gurbuz, et al., Effect of N-Acetyl Cysteine on Helicobacter pylori, in Southern Medical ... 98, n. 11, 2005, pp. 1095-1097. ^ (EN) Cammarota, et al., Biofilm demolition and antibiotic treatment to eradicate resistant ...
... of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase ... 1003-11, DOI:10.1002/jbmr.5650060915, PMID 1838661. ^ HW. Woitge, H. Oberwittler; S. Heichel; A. Grauer; R. Ziegler; MJ. Seibel ... 11, n. 28, 2005, pp. 3711-28, PMID 16305506. ^ EY. Pyon, Once-monthly ibandronate for postmenopausal osteoporosis: review of a ...
Yu Q, Stamenkovic I, Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor ... Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein, in ... 11, n. 3, 2016, pp. 998-1004, DOI:10.3892/etm.2016.2969, PMC 4774370, PMID 26998027. ^ Reed KL, Fruin AB, Bishop-Bartolomei KK ...
Yu, Q. and Stamenkovic, I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and ... 265-273 ^ Stetler-Stevenson W.G., Aznavoorian S., Liotta L.A.(1993) Tumor cell interactions with the extracellular matrix ... Latent transforming growth factor-beta binding proteins (LTBPs) structural extracellular matrix proteins for targeting TGF-beta ... Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J. ...
... evaluation of reduced glutathione levels and matrix metalloproteinase secretion., in J Ethnopharmacol, vol. 127, n. 3, Feb 2010 ... 24, n. 11, Nov 2005, p. 479, PMID 16334651. ^ PE. Beattie, RS. Dawe; NJ. Traynor; JA. Woods; J. Ferguson; SH. Ibbotson, Can St ... 14, n. 11, Nov 2001, pp. 1529-34, PMID 11712911. ^ A. Caceres, BR. Lopez; MA. Giron; H. Logemann, Plants used in Guatemala for ... 306-11, DOI:10.1159/000148223, PMID 18667843. ^ A. Boiy, R. Roelandts; J. van den Oord; PA. de Witte, Photosensitizing activity ...
... matrix metalloproteinase 9, and cyclin D1 (PDF), in Cancer Res., vol. 63, n. 15, 2003, pp. 4375-83, PMID 12907607. ^ Pathak AK ... Yong-Ri Jin, Jing-Ling Jin, Cheng-Hao Li, Xi-Xu Piao e Nan-Ge Jin, Ursolic acid enhances mouse liver regeneration after partial ...
N. Buduneli, S. Vardar; G. Atilla; T. Sorsa; H. Luoto; H. Baylas, Gingival crevicular fluid matrix metalloproteinase-8 levels ... Il volume di distribuzione è basso, circa 11 L. L'emivita plasmatica del farmaco si aggira intorno alle 20 ore. Meloxicam viene ...